A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 60
- Population
- ALL · 55 Years
- Duration
- 2024-09-30 to 2029-08-31
- Intervention
- Light Exposure; Placebo
- Comparator
- Dim Red Light
- Outcomes measured
- 24h plasma norepinephrine — Enrollment to the end of treatment at 10 weeks.; Clonidine suppression test — Enrollment; Wake after sleep onset (WASO) — Enrollment to the end of treatment at 10 weeks.; Slow oscillatory activity during sleep — Enrollment to the end of treatment at 10 weeks.; Pittsburg Sleep Quality Index — Enrollment to the end of treatment at 10 weeks.; NIH tool box — Enrollment to the end of treatment at 10 weeks.; 24-h plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) — Enrollment to the end of treatment at 10 weeks.; 24-h plasma cortisol levels — Enrollment to the end of treatment at 10 weeks.; 24h plasma melatonin — Enrollment to the end of treatment at 10 weeks.; Pupillometry — Enrollment to the end of treatment at 10 weeks.; Psychomotor Vigilance Test — Enrollment to the end of treatment at 10 weeks.; Wake EEG — Enrollment to the end of treatment at 10 weeks.; Heart Rate and Heart Rate Variability — Enrollment to the end of treatment at 10 weeks.; Insomnia Severity Index — Enrollment to the end of treatment at 10 weeks.; Visual Analogue Scale — Enrollment to the end of treatment at 10 weeks.
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sleep · 100%Title contains controlled term: sleep. Abstract contains controlled term: sleep. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.